Antitumor activity and safety of tivozanib (AV-951) in a phase II randomized discontinuation trial in patients with renal cell carcinoma (Q42643751)
Jump to navigation
Jump to search
scientific article published on 9 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antitumor activity and safety of tivozanib (AV-951) in a phase II randomized discontinuation trial in patients with renal cell carcinoma |
scientific article published on 9 April 2012 |
Statements
1 reference
Antitumor activity and safety of tivozanib (AV-951) in a phase II randomized discontinuation trial in patients with renal cell carcinoma (English)
1 reference
Dmitry A Nosov
1 reference
Brooke Esteves
1 reference
Oleg N Lipatov
1 reference
Alexei A Lyulko
1 reference
A A Anischenko
1 reference
Raju T Chacko
1 reference
Dinesh C Doval
1 reference
Andrew Strahs
1 reference
William J Slichenmyer
1 reference
Pankaj Bhargava
1 reference
9 April 2012
1 reference
1 reference
Identifiers
1 reference